StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report released on Sunday morning. The brokerage issued a hold rating on the stock. A number of other brokerages have also issued reports on CANF. HC Wainwright decreased their price target on Can-Fite BioPharma from $34.00 to $18.00 and set […]
More Stories
World News in Brief: Mpox update, Haiti displacement, deadly strikes in Ukraine, Pakistan attack condemned
The mpox outbreak continues to constitute a public health emergency of international concern, the World Health Organization (WHO) said in...
Matt Gaetz Says He’s Not Returning to Congress Next Year
By Jack Phillips Former Florida Congressman Matt Gaetz on Friday responded to speculation that he could return to the U.S....
Economic Optimism Rises as Business Activity Soars to 31-Month High
By Tom Ozimek Business activity in the United States surged in November to its highest level in nearly three years,...
Children and amputees bear brunt of Myanmar’s deadly landmine epidemic
Myanmar has become the world’s deadliest country for landmine and unexploded ordnance casualties, with over 1,000 victims in 2023 alone,...
Integrated Investment Consultants LLC Acquires Shares of 1,840 The Trade Desk, Inc. (NASDAQ:TTD)
Integrated Investment Consultants LLC bought a new position in The Trade Desk, Inc. (NASDAQ:TTD – Free Report) during the third...
Navellier & Associates Inc. Purchases New Position in Fortinet, Inc. (NASDAQ:FTNT)
Navellier & Associates Inc. bought a new stake in shares of Fortinet, Inc. (NASDAQ:FTNT – Free Report) during the 3rd...